The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial

DiscussionThis trial is designed to examine the efficacy ofrikkunshito (TJ-43) for reducing anorexia and maintaining food intake caused by cisplatin-including chemotherapy in patients with lung cancer.Trial registrationJapan Pharmaceutical Information Center Clinical Trials Information (JAPIC CTI), trial registration: JAPICCTI-142747. Registered on 15 December 2014; the RICH trial.
Source: Trials - Category: Research Source Type: clinical trials